Evidence map›Paper›PMID 41044176›Full record

ArticleScientific reports2025

An ensemble model based on transfer learning for the early detection of Alzheimer's disease.

Zahra Asghari Varzaneh, Seyyed Mohammad Mousavi, Reza Khoshkangini, Sayyed Mostafa Moosavi Khaliji

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zahra Asghari VarzanehDepartment of Computer Science and Media Technology, Sustainable Digitalisation Research Center, Malmö University, Malmö, Sweden. Zahra.asghari-varzaneh@mau.se.
Seyyed Mohammad MousaviHealth Information Sciences Department, Faculty of Management and Medical Information Sciences, Kerman University of Medical Sciences, Kerman, Iran. mr.mousavi.khj@gmail.com.
Reza KhoshkanginiDepartment of Computer Science and Media Technology, Sustainable Digitalisation Research Center, Malmö University, Malmö, Sweden.
Sayyed Mostafa Moosavi KhalijiDepartment of Research and Technology Activities Support of Kerman Provincial Unit, University of Applied Science and Technology, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the gradual decline in cognitive functions, particularly memory and reasoning. Early detection, especially during cognitive impairment (MCI) stage, is crucial for timely intervention and management. Enhanced diagnostic methods are essential for facilitating early identification and improving patient outcomes. This study presents a robust deep learning framework for the early detection of Alzheimer's disease. It employs transfer learning and hyperparameter-tuning of InceptionResnetV2, InceptionV3, Xception architectures to enhance feature extraction by leveraging their pre-trained capabilities. An ensemble voting mechanism has been integrated to combine predictions from different models, optimizing both accuracy and robustness. The proposed ensemble voting approach demonstrated exceptional performance, achieving 98.96% accuracy and 100% precision for predicting classes Mildly Demented and Moderately Demented. It outperformed baseline and state-of-the-art models, highlighting its potential as a reliable tool for early diagnosis and intervention.

Indexed as

Alzheimer DiseaseDeep LearningAgedCognitive DysfunctionEarly DiagnosisHumansAlzheimer’s diseaseConvolutional neural networkEnsemble learningMedical imagingTransfer learning

Identifiers

PMID41044176
PMCPMC12494874

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.